Key figures

SEK million, unless otherwise stated

2018

Jul-Sep

2017

Jul-Sep

2018

Jan-Sep

2017

Jan-Sep

12 mth

Oct 2017 - Sep 2018

12 mth

Oct 2016 - Sep 2017

 

 

 

 

 

 

 

Net revenues

216.6

166.2

556.0

452.6

747.0

637.3

whereof Zubsolv® US net revenue

165.4

121.1

454.9

359.3

581.4

487.5

Cost of goods sold

-42.4

-32.1

-128.4

-114.1

-178.7

-159.0

Operating expenses

-139.6

-93.2

-369.4

-311.3

-480.0

-428.6

EBIT

34.6

40.9

58.2

27.2

88.2

49.8

EBIT margin, %

16.0

24.6

10.5

6.0

11.8

7.8

US EBIT

55.6

31.8

136.5

54.0

156.2

51.6

US EBIT margin, %

33.6

26.3

30.0

15.0

26.9

10.6

EBITDA

39.8

46.1

73.7

42.8

109.0

67.1

Earnings per share, before dilution, SEK

1.80

0.82

2.50

-0.10

3.27

0.55

Earnings per share, after dilution, SEK

1.77

0.81

2.46

-0.10

3.26

0.55

Cash flow from operating activities

24.5

92.3

170.4

169.6

147.4

241.0

Cash and cash equivalents

516.6

370.7

516.6

370.7

516.6

370.7